Skip to content

Clinical trials

Phase 3 Heart Failure trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Finland Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20081
20091
20131
20142
20161
20182
20191
20201
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Bayer3
Amgen2
AstraZeneca2
Biogen1
CSL Behring1
Lexicon Pharmaceuticals1
Novo Nordisk A/S1
Paijat-Hame Hospital District1
Queen Mary University of London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure18
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
Ventricular Dysfunction, Left2
Acute Coronary Syndrome1
Anemia1
Atherosclerosis1
Atrial Fibrillation1
Coronary Artery Disease1
Coronary Disease1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.